HealthMyne, Inc. and Moffitt Cancer Center Sign Imaging Analytics Technology Agreement

Published on:

MADISON, WISCONSIN (October 6, 2015) – HealthMyne, Inc., a clinical imaging informatics company, has agreed to a research and product evaluation agreement with Moffitt Cancer Center. The primary objective of the agreement is the implementation of an imaging analytics software platform, with an initial focus on thoracic oncology.

“We are very excited to reach this important milestone with Moffitt.  Their investigators are global leaders in oncology research and care and are pioneering the exciting new field of radiomics,” stated Praveen Sinha, HealthMyne CEO.  “Quantitative imaging analysis and patient cohort comparisons can effectively and efficiently offer REAL big data benefits to both researchers and clinical care team members alike.”

One important component of the technology agreement is a structured, mineable repository of de-identified tumor descriptors that will allow investigators to evaluate samples for imaging biomarkers.  “The tumor characterization and data mining capabilities that the HealthMyne solution provides will help to accelerate our efforts to identify and validate important radiomic signatures,” said to Robert J. Gillies, PhD, chair of the Department of Cancer Imaging and Metabolism at Moffitt.  “We have moved from viewing images as pictures to seeing them as data, and that is a very empowering clinical care step.”

About HealthMyne, Inc.
HealthMyne, Inc. is a healthcare IT company that brings evidence-based imaging analysis and
actionable insights to radiologists and oncologists at the point of care. The company’s unique approach to clinical imaging enables healthcare providers to optimize individual patient care, while lowering overall care cost. The company was founded in 2013 by a seasoned group of highly successful healthcare industry entrepreneurs. For more information, visit healthmyne.com.
 

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.